Search results
FDA reverses order taking Juul vaping products off the market in US
KVUE-TV Austin· 17 hours agoE-cigarette company Juul could eventually be allowed to resume selling its products in the U.S. Back...
Geron shares surge after U.S. FDA approves blood disorder drug
Reuters· 2 hours ago, opens new tab rose more than 16% on Friday before markets opened, a day after the...
FDA Advisers Overwhelmingly Oppose Approval of MDMA As a Psychotherapeutic Catalyst
Reason.com via Yahoo News· 2 days agoMAPS Efforts to make MDMA legally available as a psychotherapeutic catalyst hit a daunting roadblock...
FDA Reverses Ban on Juul E-Cigarettes
Homenewshere.com· 15 hours agoOn June 6, the Food and Drug Administration announced that it has reversed its ban on Juul e-cigarettes while the agency reviews new information. NBC...
FDA rescinds 2022 Juul ban, company to pursue marketing authorization
Investing.com· 1 day agoFDA rescinds 2022 Juul ban, company to pursue marketing authorization
FDA analysis raises no major concerns about Eli Lilly Alzheimer's drug
KSL Salt Lake City· 1 day agoAn FDA analysis of trial data for Eli Lilly's experimental Alzheimer's drug donanemab released on...
FDA panel OKs new COVID vaccine for fall
Medical Xpress· 19 hours agoThe FDA is expected to formally recommend a new variant target for vaccine makers in the coming weeks, the Times reported. Dr. Peter Marks, who oversees...
FDA Advisors Recommend Against Using MDMA for PTSD Treatment
Time via Yahoo News· 2 days agoCredit - Getty Images/Image Source A panel of experts advising the U.S. Food and Drug Administration...
FDA rejects MDMA for PTSD treatment
Boing Boing· 11 hours agoAn FDA panel voted against allowing for MDMA to be used in treating PTSD earlier this week. Clearly, whoever was on the panel hadn't ever been to a three-day rave in the desert ...
FDA Selects Moderna's Rare Disease Candidate For Accelerated Development Program - Moderna...
Benzinga· 22 hours agoThursday, the FDA selected Moderna Inc’s MRNA mRNA-3705 for the Support for Clinical Trials Advancing Rare Disease Therapeutics (START) pilot program. “Selection for this ...
